Top Markets
Coin of the day
Taiwan Advance Bio-Pharmaceutical Inc. Taiwan Advance Bio-Pharmaceutical Inc.

Taiwan Advance Bio-Pharmaceutical Inc.

4186
Rangering i aksjer #29152
Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a... Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a substantial international presence, conducting operations across numerous countries such as China, Germany, the USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, and Pakistan, in addition to other global markets. Founded in 1989 and headquartered in New Taipei City, Taiwan, the company delivers a comprehensive array of products and services. Its offerings encompass diagnostic kits for ensuring food safety, alongside tailored customization services for ELISA, rapid, and chemical test kits, and expert consultation for setting up food safety laboratories. The firm also specializes in manufacturing both monoclonal and polyclonal antibody products. Furthermore, its portfolio includes rapid screening tests for illicit substances. It provides essential cell banking services for the secure preservation of both newborn and adult stem cells. The company also operates a dedicated drug testing facility, performing analyses on urine and hair samples to detect and identify drug abuse.
Aksjekurs
$0.2518483
Markedsverdi
$22.67M
Endring (1 dag)
-1.61%
Endring (1 år)
-31.34%
Land
TW
Handel Taiwan Advance Bio-Pharmaceutical Inc. (4186)

Kategori

Inntekter for Taiwan Advance Bio-Pharmaceutical Inc. (4186)
Inntekter i 2026 TTM: 0
Ifølge Taiwan Advance Bio-Pharmaceutical Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Taiwan Advance Bio-Pharmaceutical Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$5.27B -
US
$-3.09B -
US
$1.95B -
NL
$1.61B -
AU
- -
CH